CatrionaHJamiesonMD

PubMed

• 30 citations
  Selective antisense oligonucleotide inhibition of human IRF4 prevents malignant myeloma regeneration via cell cycle disruption
  Phoebe Mondala, Ashni A. Vora, Tianyuan Zhou, Elisa Lazzari, Luisa Ladel
  Cell Stem Cell. 2021-04-01
• 220 citations
  The JAK2 V617F mutation occurs in hematopoietic stem cells in polycythemia vera and predisposes toward erythroid differentiation
  Catriona Jamieson, Jason Gotlib, Jeffrey Durocher, Mark P. Chao, M. Rajan Mariappan
  Proceedings of the National Academy of Sciences of the United States of America. 2006-04-18
• 323 citations
  Safety and Efficacy of TG101348, a Selective JAK2 Inhibitor, in Myelofibrosis
  Animesh Pardanani, Jason Gotlib, Catriona Jamieson, Jorge E. Cortes, Moshe Talpaz
  Journal of Clinical Oncology. 2011-03-01

Abstracts/Posters

• Cirmtuzumab, a ROR1 Targeted Mab, Reverses Cancer Stemness, and Its Combination with Ibrutinib Is Safe and Effective: Planned Analysis of the Cirll Phase 1/2 Trial for...
  Catriona Jamieson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Cirmtuzumab, a ROR1 Targeted Mab, Reverses Cancer Stemness, and Its Combination with Ibrutinib Is Safe and Effective: Planned Analysis of the Cirll Phase 1/2 Trial for...
  Catriona Jamieson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Results from a Phase 2 Study of Navitoclax in Combination with Ruxolitinib in Patients with Primary or Secondary Myelofibrosis
  Catriona Jamieson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• A 14q32.31 Genomic-Imprinted DLK1-DIO3 microrna promotes Leukemogenesis By Inducing Stem Cell Quiescence and Inhibiting NK Cell Anti-Cancer Immunity
  Catriona Jamieson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Join now to see all

Lectures

• Inflammatory Cytokine Responsive Enzymatic Mutagenesis Fuels Myeloproliferative Neoplasm Pre-Leukemia Stem Cell Evolution 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• RNA Modifications in Hematologic Malignancies 
  60th American Society of Hematology Annual Meeting - 12/2/2018
• RNA Modifications in Hematology 
  60th American Society of Hematology Annual Meeting - 12/1/2018
• Hippo Kinase Inactivation Contributes to Del(20q) Malignancies and Cooperates with JAK2-V617F to Promote Myelofibrosis in Mice 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Genetic Modulation of Adenosine-to-Inosine RNA Editing Selectively Disrupts Inflammasome and Extracellular Matrix Genes in Multiple Myeloma 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Join now to see all